بررسی پوشش بیمه‌ای دارو در ایران در مقایسه با کشورهای منتخب

Authors

Abstract:

Introduction: in Iran, the compilation council of drug, having an advisory role, is responsible to cover medicine costs for health insurances. Health Insurance High Council also acts as the final decision maker about the admission of new drugs. This article studies how new drugs in Iran's health insurances are covered compared with some selected countries.  Methods: After collecting drug acceptance criteria from studies in selected countries, the importance of these criteria were measured by Iran's health system experts by means of a questionnaire. The differences and the reimbursement mechanism were investigated using 30 drug samples.  Results: There are specialized organizations in selected countries that decide for the new obligations of basic health insurances based on clinical and economical aspects of medicine performance criteria directly or as an advisory arm. Health insurance companies usually contract conditionally to protect new drugs commitment with the drug manufacturing companies.  Conclusions: In spite of low health and economical indicators of Iran compared with the selected countries, acceptance and continuing to repay the cost of pharmaceuticals are not associated with the amount of performance and the effects of the drugs. The acceptance of 43 percentage of drug samples is conditional to being a domestic production, the organization's budget, low price and the disease epidemiology. 57% of the samples did not have any insurance coverage. The new drug reimbursement decisions in Iran's health insurance usually last a long time (at least seven years) after accepting the drug in insurance companies of advanced countries. Iranian base health insurance companies are not actively involved in drug pricing. They control most of the reimbursement costs of drug from the demand side instead of the supply side.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

اثر بربرین در تنظیم آستروسیتهای Gfap+ ناحیه هیپوکمپ موشهای صحرایی دیابتی شده با استرپتوزوتوسین

Background: Diabetes mellitus increases the risk of central nervous system (CNS) disorders such as stroke, seizures, dementia, and cognitive impairment. Berberine, a natural isoquinolne alkaloid, is reported to exhibit beneficial effect in various neurodegenerative and neuropsychiatric disorders. Moreover astrocytes are proving critical for normal CNS function, and alterations in their activity...

full text

اثر بربرین در تنظیم آستروسیتهای Gfap+ ناحیه هیپوکمپ موشهای صحرایی دیابتی شده با استرپتوزوتوسین

Background: Diabetes mellitus increases the risk of central nervous system (CNS) disorders such as stroke, seizures, dementia, and cognitive impairment. Berberine, a natural isoquinolne alkaloid, is reported to exhibit beneficial effect in various neurodegenerative and neuropsychiatric disorders. Moreover astrocytes are proving critical for normal CNS function, and alterations in their activity...

full text

مقایسه نظام قیمت گذاری و بیمه دارو در ایران و کشورهای منتخب

Introduction: Pharmaceuticals comprise a large portion of health care expenditures, including insurance organizations expenditures. Accumulated evidence suggests that the inefficiencies of Iran's health insurance structure have led to soaring out- of- pocket payments by the beneficiaries of health insurance organizations. This study was conducted to compare pricing and reimbursement of pharmace...

full text

مقایسه نظام قیمت گذاری و بیمه دارو در ایران و کشورهای منتخب

زمینه: داروها یک بخش اساسی و با هزینه- اثربخشی بالایی از مراقبت‏های بهداشتی درمانی هستند که سهم عظیمی از هزینه‏های خانوارها را به خود اختصاص می‏دهند. از سوی دیگر نظام بیمه دارویی ایران با ساختار، سیاست‏ها و مقررات گذشته کارایی و اثربخشی لازم را نخواهد داشت. هدف: هدف پژوهش حاضر مقایسه ی نظام قیمت‏گذاری و بیمه دارو در ایران و چند کشور منتخب به منظور سازماندهی وضعیَت قیمت‏گذاری و بازپرداخت هزینه‏ها...

full text

بررسی تطبیقی استانداردهای مدارک پزشکی در کشورهای منتخب با ایران

Introduction: Challenges relating to expense and quality has induced an atmosphere in a way that decision makers at all levels are investigating objective data to evaluate healthcare organizations. Since medical records document the care of the patients, and are considered to be the first yard stick to evaluate the care rendered to the patients, His essential that they follow certain rules and ...

full text

مقایسه مدیریت خدمات سلامت روان در ایران و کشورهای منتخب

مقدمه: داشتن سلامت روانی لازمه رشد و شکوفایی انسان‌ها و در نتیجه رشد جوامع می‌باشد. لذا توجه به سلامت روانی افراد امری ضروری است و جزو مراقبت‌های بهداشتی می‌باشد. پژوهش حاضر با هدف مقایسه مدیریت خدمات سلامت روان در ایران و کشورهای منتخب انجام گرفت. روش کار: پژوهش حاضر به روش توصیفی-مقایسه ای در 5 کشور با معیارهای مشخص طی سه مرحله انجام شد. در مرحله اول یک مطالعه مروری به منظور تحلیل وضعیت موجو...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 18  issue 60

pages  7- 23

publication date 2015-07

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

No Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023